{"entity":{"type":"insider","cik":"0001945557","url":"/insider/0001945557","json_url":"/insider/0001945557.json","name":"Schafer Joshua","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2023-03-15","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Schafer Joshua","source":"filing","n_filings":6,"first_seen":"2023-03-15","last_seen":"2026-02-04"}],"transactions":[{"id":6207123,"accession":"0001945557-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001945557-26-000004","line_url":"/filing/0001945557-26-000004#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":9.1905,"price_display":"9.19","price_state":"stated","total_value":96500.25,"total_display":"96,500.25","total_whole":"96,500","shares_owned_after":62278.0,"shares_owned_after_display":"62,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":5806958,"accession":"0001945557-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001945557-26-000002","line_url":"/filing/0001945557-26-000002#line-2","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3375.0,"shares_display":"3,375","price_per_share":8.8297,"price_display":"8.83","price_state":"stated","total_value":29800.2375,"total_display":"29,800.24","total_whole":"29,800","shares_owned_after":37444.0,"shares_owned_after_display":"37,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":4282694,"accession":"0001437749-25-004069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-004069","line_url":"/filing/0001437749-25-004069#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO & EVP, Bus. Development)","role_mark":"O","role_mark_label":"Officer (CCO & EVP, Bus. Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO & EVP, Bus. Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":7.8597,"price_display":"7.86","price_state":"stated","total_value":82526.85,"total_display":"82,526.85","total_whole":"82,527","shares_owned_after":29486.0,"shares_owned_after_display":"29,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":7975472,"accession":"0001437749-23-025318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-025318","line_url":"/filing/0001437749-23-025318#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO & EVP, Bus. Development)","role_mark":"O","role_mark_label":"Officer (CCO & EVP, Bus. Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO & EVP, Bus. Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.129,"price_display":"5.13","price_state":"stated","total_value":2564.5,"total_display":"2,564.50","total_whole":"2,565","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider"},{"id":8733493,"accession":"0001437749-23-019035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-019035","line_url":"/filing/0001437749-23-019035#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO & EVP, Bus. Development)","role_mark":"O","role_mark_label":"Officer (CCO & EVP, Bus. Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO & EVP, Bus. Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.4157,"price_display":"5.42","price_state":"stated","total_value":5415.7,"total_display":"5,415.70","total_whole":"5,416","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-06-30","scope":"insider"},{"id":8517840,"accession":"0001437749-23-006771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-006771","line_url":"/filing/0001437749-23-006771#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001945557","owner_name":"Schafer Joshua","owner_display_name":"Schafer Joshua","owner_url":"/insider/0001945557","role":"Officer (CCO & EVP, Bus. Development)","role_mark":"O","role_mark_label":"Officer (CCO & EVP, Bus. Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO & EVP, Bus. Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.6089,"price_display":"4.61","price_state":"stated","total_value":9217.8,"total_display":"9,217.80","total_whole":"9,218","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Officer (CCO)","n_filings":6,"first_seen":"2023-03-15","last_seen":"2026-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001945557","retrieved_at":"2026-08-25T16:49:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}